|
gptkbp:instanceOf
|
patent
|
|
gptkbp:hasAbstract
|
The invention relates to a method for producing a protein using a recombinant host cell.
|
|
gptkbp:hasApplicationNumber
|
10/123,456
|
|
gptkbp:hasAssignee
|
gptkb:Biotech_Innovations_LLC
|
|
gptkbp:hasAwards
|
recombinant host cell
|
|
gptkbp:hasClaim
|
20 claims
|
|
gptkbp:hasCollaborationsWith
|
with industry partners
with academic institutions
|
|
gptkbp:hasDescription
|
A detailed description of the method and its applications.
|
|
gptkbp:hasExaminer
|
Jane_Smith
|
|
gptkbp:hasExhibition
|
data supporting the method
|
|
gptkbp:hasFacility
|
compliance with ethical standards
|
|
gptkbp:hasFieldOfUse
|
biotechnology
pharmaceuticals
|
|
gptkbp:hasFilingDate
|
2004-02-06
|
|
gptkbp:hasFunding
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:hasFuturePlans
|
potential for commercialization
|
|
gptkbp:hasGoals
|
transfection
|
|
gptkbp:hasImpactOn
|
biopharmaceutical industry
|
|
gptkbp:hasInternationalClassification
|
C12N_15/00
|
|
gptkbp:hasInventor
|
gptkb:Alice_Johnson
gptkb:John_Doe
|
|
gptkbp:hasLegalStatus
|
active
|
|
gptkbp:hasMember
|
available for licensing
|
|
gptkbp:hasOccupation
|
FDA_approval_pending
|
|
gptkbp:hasPartnershipsWith
|
therapeutic proteins
|
|
gptkbp:hasPatentNumber
|
6,789,561
|
|
gptkbp:hasPriorityDate
|
2004-09-14
2024-02-06
2003-02-06
|
|
gptkbp:hasPublications
|
2004-0123456 A1
|
|
gptkbp:hasRelatedPatent
|
biotechnological innovation
|
|
gptkbp:hasResearchInterest
|
gptkb:University_of_Science
molecular biology
|
|
gptkbp:hasResidence
|
increased protein yield
|
|
gptkbp:hasStudentOrganizations
|
plasmid vector
|
|
gptkbp:hasTechnicalField
|
genetic engineering
|
|
gptkbp:hasTechnology
|
cost-effective production
|
|
gptkbp:hasTitle
|
Method for producing a protein using a recombinant host cell
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,561 C28
|
|
gptkbp:isAssignedTo
|
gptkb:Biotech_Innovations_LLC
|
|
gptkbp:isAssociatedWith
|
biotechnology advancements
|
|
gptkbp:isCitedBy
|
gptkb:US_7,123,456_B2
gptkb:US_8,765,432_B1
|
|
gptkbp:isCitedIn
|
patent litigation cases
|
|
gptkbp:isFiledIn
|
gptkb:United_States
|
|
gptkbp:isFiledUnder
|
US_patent_law
|
|
gptkbp:isPartOf
|
biotechnology patents
patent portfolio
patent family
biotech research
|
|
gptkbp:isProtectedBy
|
international patents
|
|
gptkbp:isPublishedIn
|
USPTO database
|
|
gptkbp:isReferencedBy
|
scientific publications
|
|
gptkbp:isRelatedTo
|
gene cloning
protein expression
recombinant DNA technology
|
|
gptkbp:isSubjectTo
|
patent law compliance
|
|
gptkbp:isUsedIn
|
vaccine development
|
|
gptkbp:isUtilizedIn
|
clinical trials
|
|
gptkbp:isValuedFor
|
gptkb:USA
|
|
gptkbp:market
|
high market demand
|